February 11, 2022

Gauge Capital Announces Appointment of Dr. Bruce Given as an Operating Partner

Southlake, TX – Gauge Capital (“Gauge” or “the Firm”), a leading growth-oriented lower middle market private equity firm, announces the appointment of Dr. Bruce Given as an Operating Partner. Dr. Given will support the work associated with new opportunities within the pharma services sector, and brings a wealth of experience in the CRO, site management, and drug development and commercialization sectors.

Dr. Given is a veteran in the healthcare industry with approximately 30 years of experience in the pharma services sector. Most recently, he was the Chief Operating Officer of Arrowhead Pharmaceuticals (Nasdaq: ARWR), a business developing medicines that treat intractable diseases. Previously, Dr. Given served as the Chairman of the Board for ICON (Nasdaq: ICLR), the 7th largest global CRO. Additionally, Dr. Given held multiple leadership roles with Johnson and Johnson (NYSE: JNJ) including head of U.S. Sales & Marketing and Head of U.S. R&D. Dr. Given received his M.D. with honors from the University of Chicago and completed his clinical and research fellowship at Harvard Medical School.

“We are thrilled to have Bruce join the Gauge team,” said Stan Dennis, Managing Director and Operating Partner at Gauge. “Bruce brings extensive industry knowledge within pharma services and will be an invaluable asset to help source, identify, and evaluate new platform investments. We are looking forward to leveraging his expertise as we continue to focus on the pharma services sector.”

“I am thrilled to partner with Gauge and work with their healthcare team. I look forward to continuing to support Gauge’s efforts to invest alongside best-in-class businesses,” said Dr. Given.